B2M | Beta-2-microglobulin | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
B4GALT1 | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
BAG1 | BCL2-associated athanogene | Cancer-related genes
| | | | | Expressed in all |
BAG5 | BCL2-associated athanogene 5 | | | | | | Expressed in all |
BAIAP2 | BAI1-associated protein 2 | Plasma proteins
| | | | | Expressed in all |
BANP | BTG3 associated nuclear protein | | | | | | Expressed in all |
BCAP31 | B-cell receptor-associated protein 31 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
BCL9L | B-cell CLL/lymphoma 9-like | | | | | | Expressed in all |
BCLAF1 | BCL2-associated transcription factor 1 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
BID | BH3 interacting domain death agonist | Mitochondrial proteins
| | | | | Expressed in all |
BLVRB | Biliverdin reductase B (flavin reductase (NADPH)) | Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
BMP2K | BMP2 inducible kinase | Enzymes
| | | | | Expressed in all |
BTF3 | Basic transcription factor 3 | Plasma proteins
| | | | | Expressed in all |
BUB3 | BUB3 mitotic checkpoint protein | | | | | | Expressed in all |
C11orf30 | Chromosome 11 open reading frame 30 | Plasma proteins
| | | | | Expressed in all |
C17orf70 | Chromosome 17 open reading frame 70 | | | | | | Expressed in all |
C1orf198 | Chromosome 1 open reading frame 198 | Predicted secreted proteins
| | | | | Expressed in all |
C20orf112 | Chromosome 20 open reading frame 112 | | | | | | Expressed in all |
C21orf33 | Chromosome 21 open reading frame 33 | Mitochondrial proteins Predicted secreted proteins
| | | | | Expressed in all |
C8orf58 | Chromosome 8 open reading frame 58 | | | | | | Expressed in all |
C9orf78 | Chromosome 9 open reading frame 78 | | | | | | Expressed in all |
CALD1 | Caldesmon 1 | Cytoskeleton related proteins Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
CALU | Calumenin | Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
CANX | Calnexin | Cancer-related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CAPG | Capping protein (actin filament), gelsolin-like | Plasma proteins
| | | | | Expressed in all |
CAPN1 | Calpain 1, (mu/I) large subunit | Enzymes Plasma proteins
| | | | | Expressed in all |
CAPN2 | Calpain 2, (m/II) large subunit | Enzymes Plasma proteins
| | | | | Expressed in all |
CARS | Cysteinyl-tRNA synthetase | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
CASP3 | Caspase 3, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
CASP6 | Caspase 6, apoptosis-related cysteine peptidase | Cancer-related genes Enzymes
| | | | | Expressed in all |
CAST | Calpastatin | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
CBX1 | Chromobox homolog 1 | | | | | | Expressed in all |
CBX3 | Chromobox homolog 3 | Plasma proteins
| | | | | Expressed in all |
CCAR2 | Cell cycle and apoptosis regulator 2 | | | | | | Expressed in all |
CCDC104 | Coiled-coil domain containing 104 | | | | | | Expressed in all |
CCDC124 | Coiled-coil domain containing 124 | | | | | | Expressed in all |
CCDC50 | Coiled-coil domain containing 50 | Disease related genes
| | | | | Expressed in all |
CCDC6 | Coiled-coil domain containing 6 | Cancer-related genes Cytoskeleton related proteins Disease related genes
| | | | | Expressed in all |
CCDC86 | Coiled-coil domain containing 86 | | | | | | Expressed in all |
CCNB1 | Cyclin B1 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
CCNC | Cyclin C | | | | | | Expressed in all |
CCNI | Cyclin I | | | | | | Expressed in all |
CCNL2 | Cyclin L2 | Predicted secreted proteins
| | | | | Expressed in all |
CCT2 | Chaperonin containing TCP1, subunit 2 (beta) | Plasma proteins
| | | | | Expressed in all |
CCT3 | Chaperonin containing TCP1, subunit 3 (gamma) | Cytoskeleton related proteins Plasma proteins
| | | | | Expressed in all |
CCT5 | Chaperonin containing TCP1, subunit 5 (epsilon) | Disease related genes Plasma proteins
| | | | | Expressed in all |
CD2AP | CD2-associated protein | Disease related genes
| | | | | Expressed in all |
CD44 | CD44 molecule (Indian blood group) | Blood group antigen proteins Cancer-related genes CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CD63 | CD63 molecule | CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
CD68 | CD68 molecule | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |